News

Revolutionizing Health Data Research with Data2Evidence's Open Source

Revolutionizing Health Data Research with Data2Evidence's Open Source

Data4Life Empowers Researchers with Data2Evidence

In a significant move for the global health research community, Data4Life, a prominent nonprofit digital health organization, has unveiled the open-source platform known as Data2Evidence (D2E). This innovative step is designed to equip researchers and developers with sophisticated tools for integrating, managing, and analyzing diverse health data. By pursuing an open-source approach, Data4Life aims to promote scientific collaboration, boost innovation, and enhance the interoperability of health-related datasets.

Enhancing Research Capabilities with Open Source

Data2Evidence is built around the OMOP Common Data Model (CDM), which facilitates the standardization of health data. This powerful platform encourages collaboration between research institutions and public health organizations, enabling an interactive and flexible approach to data integration. Researchers can engage in cohort-based explorations, ultimately preserving participant privacy while benefiting from streamlined data management.

Streamlined Processing for Improved Outcomes

This platform is designed to adapt to various research needs, encompassing everything from longitudinal studies to generating real-world evidence. One of the standout features is its efficient data processing capability, which includes built-in data pipelines that allow for seamless data ingestion. Coupled with integrated quality control tools, it ensures the accuracy and reliability of data used in research.

Robust Analytical Tools at Your Disposal

The analytical functionality within Data2Evidence allows researchers to identify pertinent data and create interactive cohorts, enhancing their ability to analyze trends and patterns. Furthermore, the platform accommodates integration with machine learning systems, expanding the potential for advanced analytics.

Visualizing Data to Drive Insights

Data visualization is crucial in health research, and Data2Evidence excels in this area. Users can access a customizable dashboard that provides anonymized, aggregated insights, supporting more profound exploratory analysis. The ability to compare cohorts visually enhances the understanding of health data, aiding researchers in drawing meaningful conclusions.

Built for the Future: Interoperability and Scalability

The platform's foundation on the OMOP CDM empowers it with scalability and interoperability, allowing health data to be easily compared, reused, and built upon. This adherence to open standards promotes collaborative efforts, encouraging new projects to emerge within the global research landscape.

Why Open Source is Vital for Research

The significance of open source in health research cannot be overstated. It fosters trust through transparency, as open access to source code allows for independent evaluations of security and privacy measures. Additionally, the absence of licensing fees ensures cost efficiency, providing institutions with greater versatility and long-term viability.

Driving Innovation through Collaboration

Accelerated innovation is a key benefit of an open-source model. The collaborative nature of the global research community speeds up the development and introduction of new features and applications, ultimately benefitting the entire field of health research.

Inviting All Researchers to Join the Movement

Data2Evidence is aimed at enhancing multidisciplinary research, making it applicable across a variety of fields—including epidemiology, pharmacovigilance, public health, and health informatics. Institutions collaborating with the platform can utilize its capabilities to derive meaningful insights from health data, paving the way for significant scientific advancements.

A Growing Community of Users

The open-source nature of Data2Evidence positions it as a valuable resource for the extensive OHDSI community, which includes over 4,200 researchers already engaged with the OMOP CDM. This integration can significantly empower scientists as they harness standardized and interoperable health data for innovative research.

Join Us in Our Collaborative Efforts

Data4Life eagerly invites developers and researchers to actively participate in the ongoing evolution of Data2Evidence. The source code, along with comprehensive documentation and onboarding resources, is accessible on their official solution page. Those interested in leveraging Data2Evidence for unique research applications are encouraged to connect directly with the team to explore collaborative opportunities.

A Vision for the Future

The launch of Data2Evidence signifies a pivotal advancement in making health data research more transparent and efficient. As Christian Weiss, CEO of Data4Life, emphasizes, the organization looks forward to working with the global community to advance evidence-based digital health initiatives.

About Data4Life

D4L data4life gGmbH is a nonprofit digital health organization supported by the Hasso Plattner Foundation. The mission is to create a future where health data becomes a tool for advancing prevention, diagnosis, and treatment on a worldwide scale. Since its establishment in 2017, Data4Life has collaborated with distinguished research entities such as the Charité and Mount Sinai Hospital among others.

Media Contact

For media inquiries, please contact Daniela Wilberg, who can be reached via mobile at +49 162 2729163.

Frequently Asked Questions

What is Data2Evidence?

Data2Evidence is an open-source platform designed for integrating and analyzing health data to support research.

Why is open source important in health research?

Open source promotes transparency, collaboration, and innovation while reducing costs associated with licensing.

Who can use Data2Evidence?

Researchers, public health agencies, and institutions can leverage Data2Evidence for their studies and collaborative efforts.

What are the key features of Data2Evidence?

Data2Evidence offers efficient data processing, flexible analysis tools, advanced visualization capabilities, and supports interoperability.

How can developers contribute to Data2Evidence?

Developers can join the open-source community and contribute by accessing the source code and participating in ongoing development efforts.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 54

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Thanksgiving in Outer Banks: Unique Traditions Await

Updated Category News Views 115

Thanksgiving Plans Off the Beaten Path Thanksgiving in the Outer Banks isn't just another holiday; it's a whole different ball game. Imagine trading in the usual family couch-potato marathon for a beachside gathering, where the sand replaces the snow, and coastal seafood joins the turkey on your dinner table. If you've been teetering on the edge of making plans, this...

Continue Reading
AI Deception Challenges the Confidence of Fraud Defenses

Updated Category News Views 145

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 85

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
FiEE Rockets to Profitability with 382% Revenue Surge

Updated Category News Views 188

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 50

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 182

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
Terra Kaffe's Big Win with Oprah's Endorsement

Updated Category News Views 109

Terra Kaffe Hits the Jackpot with Oprah Sometimes, destiny has a way of handing out golden tickets, and for Terra Kaffe, receiving a nod from Oprah Winfrey's revered list of Favorite Things for 2026 is nothing short of that. I mean, you can't underestimate the pull Mrs. O has. Her endorsement isn’t just another celebrity pat-on-the-back, it’s a megaphone blaring...

Continue Reading

Top 5 Most Recently Viewed Articles

INSEAD's MIM Programme Achieves Strong Global Recognition

Updated Category News Views 207

INSEAD Master in Management Rankings Achievements INSEAD, known as the Business School for the World, has made a remarkable debut in the Financial Times Master in Management (MIM) Ranking, achieving an impressive #3 position globally among 100 distinguished institutions. This noteworthy entry highlights the strong quality and worldwide appeal of the INSEAD MIM programme....

Continue Reading
Jumptuit Achieves New Milestone with AI Patent for Enhanced Search

Updated Category News Views 642

Jumptuit's Innovative AI Search Patent Jumptuit proudly announces its recent achievement in securing a new patent from the U.S. Patent and Trademark Office (USPTO). Inventor Donald Leka, who is also the Founder and CEO of Jumptuit, has successfully obtained the patent titled "SYSTEM AND METHOD OF AI ASSISTED SEARCH." This development represents a significant leap in the...

Continue Reading
Lead Developer Highlights Value of Dogecoin Amid Industry Challenges

Updated Category News Views 69

Dogecoin's Unique Role in the Crypto World Dogecoin is frequently labeled as a meme coin, but it encompasses a significance that distinguishes it from many other cryptocurrencies. This viewpoint comes from its lead developer, who passionately defends Dogecoin’s value in a challenging and unpredictable market. Perspectives from the Lead Developer of Dogecoin Recently,...

Continue Reading
AMD Teams Up with US Department of Energy for Major AI Project

Updated Category News Views 174

AMD's Strategic Partnership with the U.S. Department of Energy On a recent episode of CNBC’s ‘Mad Money’ show, Jim Cramer, the well-known host, expressed his excitement over a substantial victory for Advanced Micro Devices Inc. (NASDAQ: AMD). The company has established a transformative partnership with the U.S. Department of Energy, worth a staggering $1 billion....

Continue Reading
Visionary Holdings Inc. Drives Governance Forward at AGM

Updated Category News Views 317

Reinventing Governance: Visionary Holdings Inc. Concludes AGM Toronto is buzzing with excitement following the successful conclusion of Visionary Holdings Inc.'s Annual General Meeting (AGM), a pivotal event in the company's calendar. This online gathering, held via Zoom, was a chance for stakeholders to witness significant corporate developments that promise to steer the...

Continue Reading